• About Eurand
  • Management
  • Board of Directors
  • Locations
• Products
  • Commercialized Products
  • In-licensing Strategy
  • Products for Out-licensing
• Development Pipeline
  • EUR-1008 (U.S.)
  • EUR-1008 (Ex-U.S.)
  • EUR-1000
  • EUR-1073
  • EUR-1025
• Pharmaceutical Technologies
  • Intellectual Property
  • Bioavailability Enhancement
  • Customized Drug Release
  • Taste-Masking and ODTs
  • Drug Conjugation
  • Case Studies
  • Our Partners
  • Manufacturing
• News and Publications
  • News
  • Conferences
  • Journal Articles
  • Scientific Papers
  • Posters
• Investor Relations
  • Company Overview
  • Stock Information
  • Financial Information
  • Corporate Governance
  • News
  • Events & Presentations
  • Shareholder Meeting
  • Investor Contacts
  • FAQ
• Careers
  • Eurand U.S. at a Glance
  • Eurand Europe at a Glance
  • Career Events
  • Employee Testimonials

Home » News and Publications » News

© 2002-2010 Eurand. All rights reserved.

Site Map | Terms and Conditions | Privacy Policy